Author of the article:Published Jul 09, 2024 • 4 minute readSPRING, Texas, July 09, 2024 (GLOBE NEWSWIRE) — Io Therapeutics, ...
Read moreDetails(Reuters) -Lenz Therapeutics said on Wednesday its lead experimental drug being tested in patients with a common age-related eye disorder ...
Read moreDetailsBerlin, Germany, San Diego, CA, USA, September 18, 2023 – Vividion Therapeutics, Inc. (Vividion), announced today that it has initiated ...
Read moreDetailsPatients meeting the selection criteria are currently being pre-screened for entry into the Phase 2 Depression trialEthics and clinical trials ...
Read moreDetailsBig Health, a developer of digital therapeutics for insomnia and anxiety, is acquiring Limbix and its SparkRx adolescent depression therapeutic. ...
Read moreDetailsCAMBRIDGE, Mass., May 31, 2022 - BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, ...
Read moreDetailsSAN DIEGO - June 23, 2022 - Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high ...
Read moreDetailsAbeona Therapeutics (Nasdaq: ABEO), a clinical-stage biopharmaceutical firm based in Cleveland, announced it has raised $25 million from "select existing ...
Read moreDetails
The Earth News is an independent English-language daily published Website from all around the World News
